Clearance Summary
FLUORESCENT ANTI. ANTI-HUMAN C3 received FDA 510(k) clearance under submission number K771583, sponsored by Burroughs Wellcome Co.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Immunology review panel. The statutory decision date of record is 1977-09-02.
- Submission: K771583
- Applicant / Sponsor: Burroughs Wellcome Co.
- Clearance pathway: Traditional
- Review panel: Immunology
- Device class: Class II
- Regulation citation: 21 CFR 866.5260
- Decision date: 1977-09-02
Classification & Regulation
This clearance is catalogued under FDA product code DAC and 21 CFR 866.5260, within the Immunology review panel as a Class II device.